European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma

IF 2 Q3 HEALTH POLICY & SERVICES Journal of Cancer Policy Pub Date : 2023-08-25 DOI:10.1016/j.jcpo.2023.100438
Alessandro Bozzao , Damien Weber , Simon Crompton, Graça Braz, Dégi Csaba, Frederic Dhermain, Gaetano Finocchiaro, Thomas Flannery, Christof Kramm, Ian Law, Gianluca Marucci, Kathy Oliver, Christoph Ostgathe, Rosina Paterra, Gianfranco Pesce, Marion Smits, Riccardo Soffietti, Robert Terkola, Colin Watts, Alberto Costa, Philip Poortmans
{"title":"European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma","authors":"Alessandro Bozzao ,&nbsp;Damien Weber ,&nbsp;Simon Crompton,&nbsp;Graça Braz,&nbsp;Dégi Csaba,&nbsp;Frederic Dhermain,&nbsp;Gaetano Finocchiaro,&nbsp;Thomas Flannery,&nbsp;Christof Kramm,&nbsp;Ian Law,&nbsp;Gianluca Marucci,&nbsp;Kathy Oliver,&nbsp;Christoph Ostgathe,&nbsp;Rosina Paterra,&nbsp;Gianfranco Pesce,&nbsp;Marion Smits,&nbsp;Riccardo Soffietti,&nbsp;Robert Terkola,&nbsp;Colin Watts,&nbsp;Alberto Costa,&nbsp;Philip Poortmans","doi":"10.1016/j.jcpo.2023.100438","DOIUrl":null,"url":null,"abstract":"<div><p>European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCCs) are explanations of the organisation and actions necessary to provide high-quality care to patients with a specific cancer type. They are compiled by a working group of European experts representing disciplines involved in cancer care, and provide oncology teams, patients, policymakers and managers with an overview of the essential requirements in any healthcare system. The focus here is on adult glioma. Gliomas make up approximately 80% of all primary malignant brain tumours. They are highly diverse and patients can face a unique cognitive, physical and psychosocial burden, so personalised treatments and support are essential. However, management of gliomas is currently very heterogeneous across Europe and there are only few formally-designated comprehensive cancer centres with brain tumour programmes. To address this, the ERQCC glioma expert group proposes frameworks and recommendations for high quality care, from diagnosis to treatment and survivorship. Wherever possible, glioma patients should be treated from diagnosis onwards in high volume neurosurgical or neuro-oncology centres. Multidisciplinary team working and collaboration is essential if patients’ length and quality of life are to be optimised.</p></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538323000553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCCs) are explanations of the organisation and actions necessary to provide high-quality care to patients with a specific cancer type. They are compiled by a working group of European experts representing disciplines involved in cancer care, and provide oncology teams, patients, policymakers and managers with an overview of the essential requirements in any healthcare system. The focus here is on adult glioma. Gliomas make up approximately 80% of all primary malignant brain tumours. They are highly diverse and patients can face a unique cognitive, physical and psychosocial burden, so personalised treatments and support are essential. However, management of gliomas is currently very heterogeneous across Europe and there are only few formally-designated comprehensive cancer centres with brain tumour programmes. To address this, the ERQCC glioma expert group proposes frameworks and recommendations for high quality care, from diagnosis to treatment and survivorship. Wherever possible, glioma patients should be treated from diagnosis onwards in high volume neurosurgical or neuro-oncology centres. Multidisciplinary team working and collaboration is essential if patients’ length and quality of life are to be optimised.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
欧洲癌症组织对癌症优质护理的基本要求:成人神经胶质瘤
欧洲癌症组织对癌症优质护理的基本要求(ERQCC)解释了为特定癌症类型的患者提供优质护理所需的组织和行动。它们由代表癌症护理学科的欧洲专家工作组汇编,并为肿瘤团队、患者、政策制定者和管理者提供任何医疗系统的基本要求概述。这里的重点是成人胶质瘤。胶质瘤约占所有原发性恶性脑肿瘤的80%。他们具有高度的多样性,患者可能面临独特的认知、身体和心理负担,因此个性化的治疗和支持至关重要。然而,目前整个欧洲对胶质瘤的管理非常异质,只有少数几个正式指定的综合性癌症中心有脑瘤项目。为了解决这一问题,ERQCC神经胶质瘤专家组提出了从诊断到治疗和存活的高质量护理框架和建议。只要可能,神经胶质瘤患者应从诊断开始就应在大容量神经外科或神经肿瘤中心接受治疗。如果要优化患者的寿命和生活质量,多学科团队合作至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
期刊最新文献
Palliative Care in Turkey: Insights from experts through key informant interviews Is health-related quality of life sufficiently addressed in trials for breast cancer treatments? An assessment based on reimbursement opinions from the French health technology assessment body, 2009–2023 Shaping the future research agenda of Cancer Nursing in Italy: Insights and strategic directions Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients Artificial Intelligence and cancer: Profile of registered clinical trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1